Juul Labs CEO Announces Company's Next Steps

Oct.09.2022
Juul Labs CEO Announces Company's Next Steps
Juul CEO announces cancellation of overseas expansion plans, debt refinancing, and potential bankruptcy as the company fights for survival.

Recently, the CEO of Juul Labs Inc., KC Crosthwaite, announced that the company is canceling its plans for international expansion. They have also undergone a refinancing process for some of their debts and are currently struggling to keep the business afloat.


The board of directors, leadership team, and I are continuing to evaluate all options to ensure that we take the necessary steps to help us fight for our mission - a battle that has been going on for many years," said CEO KC Crosthwaite in a statement.


In the ongoing dispute with the U.S. Food and Drug Administration (FDA) over whether its e-cigarettes can remain on the U.S. market, Juul has been preparing to file for bankruptcy protection. Crosthwaite stated that the company is still considering various restructuring plans, including bankruptcy, but has not made any decisions yet.


Crosthwaite announced that the company will be laying off some employees after cancelling its plans to expand outside of the United States. He also stated that Juul has successfully refinanced its debt to allow for more time to explore longer-term options.


We firmly believe that we have a future in which millions of adult smokers around the world will be able to use Juul products," said Crosthwaite. "To make this future a reality, we must continue to fight and make difficult decisions.


In 2018, Juul disrupted the tobacco market when its stylish flash-drive shaped vaporizer drove a surge in electronic cigarette use in the United States. Since then, Juul has faced lawsuits and regulatory crackdowns. The company has attempted to repair its image by appointing a new CEO in 2019 and voluntarily discontinuing the sale of fruit flavors in the US, as well as ceasing most of its marketing activities in the country.


Juul Labs CEO KC Crosthwaite has announced that the company will be laying off employees following a decision to withdraw plans for international expansion. Juul, which had approximately 3,000 employees in 2019, has already cut two-thirds of its workforce due to declining sales and increased losses. The company currently employs around 1,200 workers, including approximately 100 outside of the US, and the impact of the latest layoff decisions on their positions is unclear at this time.


The company Juul had previously planned to expand distribution in Canada, with their latest device JUUL2 launching earlier this year and being sold online and in around three dozen stores in Toronto. Juul also plans to re-establish employees in Italy and Switzerland, where their original e-cigarettes are currently sold through local distributors.


In 2020, due to a voluntary decision to reduce marketing efforts and cease sales of their sweet and fruity flavors in the United States, the company withdrew from most international markets as a result of declining revenue. In June, the FDA ordered Juul to remove their e-cigarettes from the U.S. market, stating insufficient proof of safety. The agency subsequently suspended the order pending Juul's appeal. However, sources reveal that Juul's sales in the U.S. continued to decline, prompting the company to abandon their overseas plans.


Juul faces thousands of lawsuits accusing the company of selling its products to children. Some of these lawsuits are scheduled to go to trial next year. Disputes with the FDA have hindered Juul's ability to raise funds or obtain traditional bank loans to pay for legal settlements or court judgments.


Since last year, Juul has agreed to pay over $525 million in settlements to several states that have been investigating or taking legal action against the company. There are still pending cases, including lawsuits filed by nine other attorneys general. The company maintains that it has never targeted underage users.


According to a federal investigation released on Thursday, Juul did not make it to the list of the most popular e-cigarette brands used by high school students.


Statement:


This article is compiled based on third-party information and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of the article's content. The compilation of this article is only intended for industry-related communication and research.


Due to limitations in our translation capabilities, the translated article may not fully express the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government in regards to any domestic, Hong Kong, Macao, Taiwan, or foreign-related statements and positions.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

PMI Brazil CEO Urges Policy Rethink, Backs Smoke-Free Alternatives Like IQOS and Zyn
PMI Brazil CEO Urges Policy Rethink, Backs Smoke-Free Alternatives Like IQOS and Zyn
Branko Svarcic, CEO of Philip Morris Brazil, says the country should rethink its public health approach, especially on e-cigarettes and heated tobacco. While Brazil has banned e-cigarettes since 2009, products like IQOS and Zyn are seen as harm-reduction tools in many countries. He urged the government to learn from global examples and update its policies.
May.26 by 2FIRSTS.ai
GEEKBAR Launches Pod Vape with Display Screen: Dual Compatibility for Ceramic & Mesh Coils
GEEKBAR Launches Pod Vape with Display Screen: Dual Compatibility for Ceramic & Mesh Coils
GEEKBAR has introduced two new refillable pod vapes, the Visionmax and Visioneco, both featuring built-in screens and a 1,200-puff capacity. The Visionmax model includes a touchscreen interface, while the Visioneco is equipped with a smaller display. Designed for versatility, both devices support interchangeable ceramic coils and mesh coils, catering to diverse user preferences.
Apr.25 by 2FIRSTS.ai
2Firsts Insight | DOJO Launches Own E-Liquid Brand, Set to Hit Shelves in Germany
2Firsts Insight | DOJO Launches Own E-Liquid Brand, Set to Hit Shelves in Germany
The e-cigarette brand DOJO has unveiled DOJOLIQ, its self-developed e-liquid line co-created with the VAPORESSO team. The product comes in 10ml bottles and features 10 flavors, primarily fruit-based. It is now listed on several German online vape retail platforms and will be available for purchase soon.
Jun.10 by 2FIRSTS.ai
From “2+10” Market Saturation to Prime Time: CFU Vaping Experience Offers a New Compliance Blueprint
From “2+10” Market Saturation to Prime Time: CFU Vaping Experience Offers a New Compliance Blueprint
At Vaper Expo UK, CFU Vaping Experience launched Prime 2ML, a superior alternative to traditional disposables, and Prime 10ML, a compliant solution for legal big puff. MixIn, the first smart hybrid device combining harm reduction with enhanced flavor, provides a viable option for smokers. Through technological innovation, CFU has brought sustainable solutions to the industry, leading it into a new “Prime Time.”
May.12
SKE Launches Compact All-in-One Replaceable Pod E-Cigarette
SKE Launches Compact All-in-One Replaceable Pod E-Cigarette
The SKE brand recently launched the SKE BAR, a small capacity refillable e-cigarette with an integrated replaceable cartridge system PCTG material, which has been publicized by the UK FDA. The product is aimed at the UK market and pricing information is currently TBD.
Apr.24 by 2FIRSTS.ai
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
The U.S. Food and Drug Administration has officially launched Elsa, a generative AI tool designed to speed up clinical reviews, internal writing, and data processing tasks. After successful pilots across multiple departments, Elsa is now being rolled out agency-wide.
Jun.04 by 2FIRSTS.ai